NCT05908643 — Neogap Therapeutics cancer immunotherapy trial
A First-In-Human Trial of pTTL in Advanced Colorectal Cancer
Registry record
| Registry ID | NCT05908643 ↗ |
|---|---|
| Lead sponsor | Neogap Therapeutics AB |
| Collaborators | CTC Clinical Trial Consultants AB, Karolinska University Hospital, Region Västmanland, Vecura |
| Phase | Phase 1/2 |
| Status | Active Not Recruiting |
| Indication | Colorectal Cancer |
| Enrollment | 16 participants (target) |
| Start date | 2023-03-15 |
| Primary completion | 2030-12 (est.) |
| Last registry update | 28 Oct 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT05908643), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
Daily coverage of the modality, tumor type and players this study touches:
Related trials
FAQ
What phase is NCT05908643?
NCT05908643 (A First-In-Human Trial of pTTL in Advanced Colorectal Cancer) is registered on ClinicalTrials.gov as Phase 1/2, sponsored by Neogap Therapeutics AB.
Is NCT05908643 recruiting?
As of the 2026-10-28 registry update, NCT05908643 is listed as "Active Not Recruiting". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT05908643?
The lead sponsor is Neogap Therapeutics AB. Collaborators: CTC Clinical Trial Consultants AB, Karolinska University Hospital, Region Västmanland, Vecura.
What condition does NCT05908643 study?
The registered condition is Colorectal Cancer. Primary completion is listed as 2030-12 (estimated).
Are results available for NCT05908643?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT05908643.
Back to the full neoantigen vaccine trial tracker — 106 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.